Skip to content

Zoetis ZTS Change in AR

Change in AR at other companies

Merck & Co. logo
Merck & Co.MRK
$272.5M+347%
Neogen logo
NeogenNEOG
-$5.25M-39.4%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$56.81M+25.6%
Phibro Animal Health logo
Phibro Animal HealthPAHC
-$2.33M-107%
Revvity logo
RevvityRVTY
-$61.55M-239%
Central Garden & Pet Company logo
Central Garden & Pet CompanyCENT
$245.79M+37.4%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$30.13B-54.8%
Enterprise value$38.17B-47.3%
P/E11.4×-14.4×
P/S3.2×-4.0×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's change in AR?
Zoetis (ZTS) reported change in AR of $106M in Q1 2026.
How has Zoetis's change in AR changed year-over-year?
Zoetis's change in AR increased by 130.4% year-over-year, from $46M to $106M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.